The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Evidence-based Guideline: Treatment of Parenchymal Neurocysticercosis
Neurol 80:1424-1429, Baird, R.,et al, 2013
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Variability of Brain Death Determination Guidelines in Leading US Neurologic Institutions
Neurol 70:284-289,252, Greer,D.M.,et al, 2008
Gadolinium-Based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Radiology 242:647-649, Kuo,P.H.,et al, 2007
Treatment of Neurocysticercosis: Current Status and Future Research Needs
Neurol 67:1120-1127, Nash,T.E.,et al, 2006
Determining Brain Death in Adults
Neurol 45:1003-1011, Wijdicks,E.F.M., 1995
Variability in Brain Death Determination Practices in Children
JAMA 274:550-553, Mejia,R.E.&Pollack,M.M., 1995